Literature DB >> 8926586

Statistical approach to neural network model building for gentamicin peak predictions.

B P Smith1, M E Brier.   

Abstract

Feed forward neural networks are flexible, nonlinear modeling tools that are an extension of traditional statistical techniques. The hypothesis that feed forward neural network models can be built in a similar fashion as a statistical model was tested. Feed forward neural network models were built using forward and backward variable selection, and zero to five hidden nodes, and tanh and linear transfer functions were used. Gentamicin serum concentrations were predicted as a model drug for testing these methods. Peak observations from 392 patients were used to train, test, and validate the feed forward neural network. Inputs were demographic and drug dosing information. Model selection was performed using the Akaike information criteria (AIC), Bayesian information criteria (BIC), and a method of stopped training. The models with lowest root mean square (rms) error were those with all 10 inputs and five hidden nodes. Average rms error in the validation set was lowest for stopped training (1.46), then AIC (1.51), and finally BIC (1.56). Larger models tended to result in the best predictions. Overfitting can occur in models that are too large, either by using too many nodes in the hidden layer (rms = 1.49) or by using too many inputs with little information associated with them (rms = 1.70). We conclude that neural networks can be built using a large number of parameters that have good predictive performance. Care must be used during training to avoid overfitting the data. A stopped training method resulted in the network with the lowest rms error.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926586     DOI: 10.1021/js950271l

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  A parameter sensitivity methodology in the context of HIV delay equation models.

Authors:  H T Banks; D M Bortz
Journal:  J Math Biol       Date:  2004-12-20       Impact factor: 2.259

Review 2.  Artificial neural network as a novel method to optimize pharmaceutical formulations.

Authors:  K Takayama; M Fujikawa; T Nagai
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

3.  Empirical versus mechanistic modelling: comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbiturates.

Authors:  I S Nestorov; S T Hadjitodorov; I Petrov; M Rowland
Journal:  AAPS PharmSci       Date:  1999

4.  Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.

Authors:  Tianyuan Fan; Kozo Takayama; Yoshiyuki Hattori; Yoshie Maitani
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

5.  Automatic identification of species with neural networks.

Authors:  Andrés Hernández-Serna; Luz Fernanda Jiménez-Segura
Journal:  PeerJ       Date:  2014-11-04       Impact factor: 2.984

6.  Application of Machine Learning for Tumor Growth Inhibition - Overall Survival Modeling Platform.

Authors:  Phyllis Chan; Xiaofei Zhou; Nina Wang; Qi Liu; René Bruno; Jin Y Jin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.